Mek will bring unique HHS cybersecurity, AI and blockchain experience to Equideum Health He will…
LeapYear study focuses on areas where trading desks can create competitive differentiation SAN FRANCISCO–(BUSINESS WIRE)–Now…
– FY 2021 record sales of $17,200,000 compared to $15,100,000 for FY 2020, representing a…
Data Continue to Highlight the Potential of ALLO-316 to Treat Both Solid Tumors and Hematologic…
Dr. Medarova will present at the 3rd Annual RNAi-Based Therapeutics Summit on April 20 BOSTON,…
New Research from Trinity College Dublin Indicates Broader Therapeutic Potential for ART27.13 SOLANA BEACH, Calif.,…
India’s Department of Biotechnology, Government of India to support scale up and production of cGMP batches of SARS-CoV-2…
Fort Lee, NJ, April 13, 2022 (GLOBE NEWSWIRE) — Nuvectis Pharma, Inc (NASDAQ: NVCT), (“Nuvectis”…
Urvashi Patel, Ph.D., as Vice President, Regulatory Affairs Stacey Bilinski, as Vice President, Clinical Operations…
Discontinued enrollment of Phase 1/2 trial of ONCT-216 in Ewing sarcoma Resources will be primarily…
MONTREAL, April 13, 2022 (GLOBE NEWSWIRE) — ExCellThera Inc. (ExCellThera), an advanced clinical-stage biotechnology company…
VLN® Reduced Nicotine Content Cigarettes Launch in Chicagoland Pilot VLN® 95% reduced nicotine content cigarettes…
Renibus Therapeutics granted patent approval for the novel aqueous iron composition of RBT-3, a product…
Second U.S. orphan drug designation for efzofitimod clinical program SAN DIEGO, April 13, 2022 (GLOBE…
Provides Access to Additional Capital to Support Growth WARREN, N.J., April 13, 2022 (GLOBE NEWSWIRE)…
Publication describes critical interactions between cholix-based transport domain and endogenous intracellular trafficking pathways used by…
Dose increase of R327 Dose increase of R327 Highlights: 36 subjects successfully dosed in Phase…
BOSTON, April 13, 2022 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage…
This third collaboration with the Miami VA shows Longeveron’s commitment to improving the health of…
MALVERN, Pa., April 13, 2022 (GLOBE NEWSWIRE) — Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company…